Cargando…

Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China

BACKGROUND: Cardiovascular benefits by reversing environmental risks factors for essential hypertension (EH) and dyslipidemia could be weaken by high genetic risk. We investigated possible associations between ACE2 polymorphisms and dyslipidemia in patients with EH. METHODS: Four hundred and two hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yizhi, Wang, Tianyi, Li, Yanfang, Guan, Tianwang, Lai, Yanxian, Shen, Yan, Zeyaweiding, Abudurexiti, Maimaiti, Tutiguli, Li, Fang, Zhao, Haiyan, Liu, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195726/
https://www.ncbi.nlm.nih.gov/pubmed/30342552
http://dx.doi.org/10.1186/s12944-018-0890-6
_version_ 1783364443598487552
author Pan, Yizhi
Wang, Tianyi
Li, Yanfang
Guan, Tianwang
Lai, Yanxian
Shen, Yan
Zeyaweiding, Abudurexiti
Maimaiti, Tutiguli
Li, Fang
Zhao, Haiyan
Liu, Cheng
author_facet Pan, Yizhi
Wang, Tianyi
Li, Yanfang
Guan, Tianwang
Lai, Yanxian
Shen, Yan
Zeyaweiding, Abudurexiti
Maimaiti, Tutiguli
Li, Fang
Zhao, Haiyan
Liu, Cheng
author_sort Pan, Yizhi
collection PubMed
description BACKGROUND: Cardiovascular benefits by reversing environmental risks factors for essential hypertension (EH) and dyslipidemia could be weaken by high genetic risk. We investigated possible associations between ACE2 polymorphisms and dyslipidemia in patients with EH. METHODS: Four hundred and two hypertensive patients were enrolled in an EH group and 233 normotensive individuals were enrolled as control group from the Xinjiang region of China. Fourteen ACE2 polymorphisms were genotyped by Matrix-assisted laser desorption ionization time-of-flight mass spectrometry. RESULTS: Participants carrying T allele (TT + CT) of rs2074192 (P = 0.006), rs4646155 (P = 0.030) and rs4646188 (P < 0.001), C allele (CT + CT or CC + CG) of rs4240157 (P = 0.012), rs4830542 (P = 0.020) and rs879922 (P < 0.001) and TT genotype of rs2106809 (P = 0.012) were associated with EH. Meanwhile,ACE2 SNPs also exhibited association with dyslipidemia but exhibited obvious heterogeneity. rs1978124 (TT + CT, P = 0.009), rs2106809 (TT, P = 0.045), rs233575 (CC + CT, P = 0.018), rs4646188 (CC, P = 0.011) and rs879922 (CC + CG, P = 0.003) were association with increased LDL-C (≥1.8 mmol/L). rs2106809 (CC + CT, P < 0.001), rs2285666(TT + CT, P = 0.017), rs4646142(CC + CG, P = 0.044), rs4646155(TT + CT, P < 0.001) and rs4646188(TT + CT, P = 0.033) were association with decreased HDL-C (< 1.0 mmol/L). rs2074192 (TT + CT, P = 0.012), rs4240157 (CC + CT, P = 0.027), rs4646156 (AA+AT, P = 0.007), rs4646188 (TT + CT, P = 0.005), rs4830542 (CC + CT, P = 0.047) and rs879922 (CC + CG, P = 0.001) were association with increased TC (≥5.2 mmol/L). rs2106809 (P = 0.034) and rs4646188 (P = 0.013) were associated with hypertriglyceridemia. Further, ischemic stroke was more prevalent with rs4240157 (CC + CT, P = 0.043), rs4646188 (CC + CT, P = 0.013) and rs4830542 (CC + CT, P = 0.037). In addition, rs2048683 and rs6632677 were not association with EH, dyslipidemia and ischemic stroke. CONCLUSION: The ACE2 rs4646188 variant may be a potential and optimal genetic susceptibility marker for EH, dyslipidemia and its related ischemic stroke. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12944-018-0890-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6195726
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61957262018-10-30 Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China Pan, Yizhi Wang, Tianyi Li, Yanfang Guan, Tianwang Lai, Yanxian Shen, Yan Zeyaweiding, Abudurexiti Maimaiti, Tutiguli Li, Fang Zhao, Haiyan Liu, Cheng Lipids Health Dis Research BACKGROUND: Cardiovascular benefits by reversing environmental risks factors for essential hypertension (EH) and dyslipidemia could be weaken by high genetic risk. We investigated possible associations between ACE2 polymorphisms and dyslipidemia in patients with EH. METHODS: Four hundred and two hypertensive patients were enrolled in an EH group and 233 normotensive individuals were enrolled as control group from the Xinjiang region of China. Fourteen ACE2 polymorphisms were genotyped by Matrix-assisted laser desorption ionization time-of-flight mass spectrometry. RESULTS: Participants carrying T allele (TT + CT) of rs2074192 (P = 0.006), rs4646155 (P = 0.030) and rs4646188 (P < 0.001), C allele (CT + CT or CC + CG) of rs4240157 (P = 0.012), rs4830542 (P = 0.020) and rs879922 (P < 0.001) and TT genotype of rs2106809 (P = 0.012) were associated with EH. Meanwhile,ACE2 SNPs also exhibited association with dyslipidemia but exhibited obvious heterogeneity. rs1978124 (TT + CT, P = 0.009), rs2106809 (TT, P = 0.045), rs233575 (CC + CT, P = 0.018), rs4646188 (CC, P = 0.011) and rs879922 (CC + CG, P = 0.003) were association with increased LDL-C (≥1.8 mmol/L). rs2106809 (CC + CT, P < 0.001), rs2285666(TT + CT, P = 0.017), rs4646142(CC + CG, P = 0.044), rs4646155(TT + CT, P < 0.001) and rs4646188(TT + CT, P = 0.033) were association with decreased HDL-C (< 1.0 mmol/L). rs2074192 (TT + CT, P = 0.012), rs4240157 (CC + CT, P = 0.027), rs4646156 (AA+AT, P = 0.007), rs4646188 (TT + CT, P = 0.005), rs4830542 (CC + CT, P = 0.047) and rs879922 (CC + CG, P = 0.001) were association with increased TC (≥5.2 mmol/L). rs2106809 (P = 0.034) and rs4646188 (P = 0.013) were associated with hypertriglyceridemia. Further, ischemic stroke was more prevalent with rs4240157 (CC + CT, P = 0.043), rs4646188 (CC + CT, P = 0.013) and rs4830542 (CC + CT, P = 0.037). In addition, rs2048683 and rs6632677 were not association with EH, dyslipidemia and ischemic stroke. CONCLUSION: The ACE2 rs4646188 variant may be a potential and optimal genetic susceptibility marker for EH, dyslipidemia and its related ischemic stroke. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12944-018-0890-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-20 /pmc/articles/PMC6195726/ /pubmed/30342552 http://dx.doi.org/10.1186/s12944-018-0890-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pan, Yizhi
Wang, Tianyi
Li, Yanfang
Guan, Tianwang
Lai, Yanxian
Shen, Yan
Zeyaweiding, Abudurexiti
Maimaiti, Tutiguli
Li, Fang
Zhao, Haiyan
Liu, Cheng
Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
title Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
title_full Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
title_fullStr Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
title_full_unstemmed Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
title_short Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
title_sort association of ace2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in xinjiang, china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195726/
https://www.ncbi.nlm.nih.gov/pubmed/30342552
http://dx.doi.org/10.1186/s12944-018-0890-6
work_keys_str_mv AT panyizhi associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina
AT wangtianyi associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina
AT liyanfang associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina
AT guantianwang associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina
AT laiyanxian associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina
AT shenyan associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina
AT zeyaweidingabudurexiti associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina
AT maimaititutiguli associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina
AT lifang associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina
AT zhaohaiyan associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina
AT liucheng associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina